2011
DOI: 10.1016/j.jaci.2011.07.021
|View full text |Cite
|
Sign up to set email alerts
|

Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
57
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(59 citation statements)
references
References 49 publications
2
57
0
Order By: Relevance
“…Recently, the BAT has also been shown to correlate with the ASST as well as with the results of basophil histamine release assays (BHRA), and it has been proposed as a reliable functional assay in the diagnosis of autoimmune urticaria [16]. In contrast to the ASST, the BAT: (1) does not bear the risk of accidental infection by injections of autologous serum, (2) is not influenced by the intake of antihistamines, (3) provides quantifiable results, (4) is suited for the monitoring of treatment, (5) can distinguish between patients who express anti-IgE and anti-FcεRI antibodies, and (6) can be performed in patients of any age including infants [17,18,19]. …”
Section: Introductionmentioning
confidence: 99%
“…Recently, the BAT has also been shown to correlate with the ASST as well as with the results of basophil histamine release assays (BHRA), and it has been proposed as a reliable functional assay in the diagnosis of autoimmune urticaria [16]. In contrast to the ASST, the BAT: (1) does not bear the risk of accidental infection by injections of autologous serum, (2) is not influenced by the intake of antihistamines, (3) provides quantifiable results, (4) is suited for the monitoring of treatment, (5) can distinguish between patients who express anti-IgE and anti-FcεRI antibodies, and (6) can be performed in patients of any age including infants [17,18,19]. …”
Section: Introductionmentioning
confidence: 99%
“…The discrepancy between CD63 and CD203c correlations with ASST in our study can reflect either different mechanism of CD63 and CD203c molecules upregulation or differences in methodology of tests. Recently, Gentinetta et al [16] conducted the study of basophil activation tests in CU using different basophil donors and made a conclusion that CD63 activation test using IL-3 priming could be used as alternative to ASST. In authors opinion CD203c as basophil activation marker is less suitable for this purpose as they reported variable activation patterns, rendering the discrimination between patient and healthy control serum impossible in certain basophil donors.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the ability of CU patient's serum to evoke expression of CD63 and CD203c on donor human basophils assessed by flow cytometry has been tested. There are a few published studies assessing serum-induced CD63 expression measurement as a diagnostic tool in CAU [11][12][13][14][15][16] and only 2 studies done by measured CD203c expression [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…The peripheral blood mononuclear cells were incubated with IL-3 (10 ng/ml; PeproTech EC Ltd., London, UK) for 30 min [11] and washed, then stimulated with dsDNA (1, or 10 μg/ml), rabbit anti-IgE Ab (0.1 μg/ml; DAKO Cytomation, Carpinteria, Calif., USA), or calcium ionophore A23187 (10 -6 M ) at 37°C for 30 min. A flow cytometric analysis of the mononuclear cells was performed as described previously [12].…”
Section: Methodsmentioning
confidence: 99%